Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Kiniksa Pharmaceuticals International, p - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
KNSA
Nasdaq
2830
www.kiniksa.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Kiniksa Pharmaceuticals International, p
Heart Drug Stock Rockets 20% On Sales, Boosts Outlook; Regeneron Pharma's Global Partnership Is Strong Tailwind
- Jul 1st, 2025 11:37 am
Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis
- Jun 5th, 2025 5:00 am
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
- May 29th, 2025 2:01 pm
3 Stocks Including Kiniksa Pharmaceuticals International That May Be Priced Below Intrinsic Value Estimates
- May 1st, 2025 5:38 am
US High Growth Tech Stocks To Watch In April 2025
- Apr 30th, 2025 11:38 am
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
- Apr 30th, 2025 6:30 am
An Intrinsic Calculation For Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Suggests It's 41% Undervalued
- Apr 30th, 2025 4:38 am
Kiniksa Pharmaceuticals, Ltd. (KNSA) Tops Q1 Earnings and Revenue Estimates
- Apr 29th, 2025 6:35 am
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
- Apr 29th, 2025 5:30 am
Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025
- Apr 24th, 2025 2:01 pm
uniQure (QURE) Moves 38.5% Higher: Will This Strength Last?
- Apr 21st, 2025 7:54 am
Acadia (ACAD) Stock Jumps 6.1%: Will It Continue to Soar?
- Apr 10th, 2025 7:31 am
Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year?
- Apr 8th, 2025 7:40 am
Wall Street Analysts Predict a 64.8% Upside in Kiniksa Pharmaceuticals (KNSA): Here's What You Should Know
- Apr 4th, 2025 7:55 am
How Much Upside is Left in Kiniksa Pharmaceuticals (KNSA)? Wall Street Analysts Think 58.6%
- Mar 19th, 2025 7:55 am
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
- Mar 14th, 2025 3:51 am
Is Kiniksa Pharmaceuticals International, plc (KNSA) the Best UK Growth Stock to Buy Now?
- Mar 6th, 2025 6:23 am
Surging Earnings Estimates Signal Upside for Kiniksa Pharmaceuticals (KNSA) Stock
- Mar 4th, 2025 10:20 am
Kiniksa Pharmaceuticals (KNSA) Soars 5.8%: Is Further Upside Left in the Stock?
- Mar 4th, 2025 1:05 am
Wall Street Analysts See a 73.42% Upside in Kiniksa Pharmaceuticals (KNSA): Can the Stock Really Move This High?
- Mar 3rd, 2025 7:55 am
Scroll